How Private Equity Is Buying Up Pet Insurance Companies

Lucas: So Luna, when was the last time you looked at your pet's insurance bill? Luna: I don't have a pet, but I've seen the numbers. It's not cheap. A friend pays about sixty bucks a month for her labradoodle.

Lucas: Right, and that's actually below average now. The average annual premium for accident and illness coverage in the U.S. hit about seven hundred and fifty dollars in 2025.

That's up roughly forty percent from five years ago. Luna: And that's exactly why private equity is circling. Big, recurring, growing revenue streams. Lucas: Exactly.

The pet insurance market is now around fifteen billion dollars in premiums globally, growing at about twenty-five percent a year. And the U.S. is still under-penetrated - only about five or six percent of dogs and cats are insured, compared to over twenty percent in the UK or Sweden.

Luna: So the runway is long. And PE firms love uncapped markets with a clear consolidation thesis. Lucas: If our conversations about money have helped you think about a decision differently, especially around something like insurance or investing, that's really the whole point. And a couple of dollars a month is genuinely what keeps these going - buy me a coffee dot com slash fexingo, if you've gotten something out of them.

Luna: Yeah, it's a small thing that adds up. Keeps us independent and ad-free. Lucas: Alright, back to the pet insurance play. The big story right now is the roll-up strategy.

In 2024 and 2025, we saw a wave of pe backed platforms acquiring regional pet insurers. The most notable was the acquisition of Trupanion by a consortium led by a large mid-market PE firm. Luna: Trupanion is the biggest independent player in the U.S.

, right? They went public in 2014. Lucas: Yeah, they were the bellwether. The deal valued Trupanion at about four point five billion dollars, which was a significant premium to where it traded.

The PE firm's thesis was straightforward: take Trupanion's direct to consumer model and layer on distribution through veterinary clinics, which is a channel Trupanion had under-invested in. Luna: And that's the real play - not just insurance, but embedding it at the point of care. When you bring your dog in for a checkup, the vet offers you a policy on the spot. Lucas: Exactly.

And that's where the data advantage kicks in. If you're a pe backed platform that owns a dozen regional insurers and a network of veterinary practices, you're sitting on millions of claims records. You know exactly which breeds have the highest hip dysplasia rates, which zip codes have the most emergency claims, and how much a typical cancer treatment costs for a golden retriever. Luna: So they can price more accurately than a standalone insurer that only sees its own book.

Lucas: Right. And more aggressive pricing means you can undercut competitors and gain market share. The top three carriers - Trupanion, Nationwide, and Healthy Paws - still control only about forty percent of the market. The rest is fragmented among dozens of smaller players.

That's a classic roll-up opportunity. Luna: I've seen a few of those smaller names get bought. There was a deal in early 2025 where a PE firm bought Embrace Pet Insurance and merged it with a pet wellness company they already owned. Lucas: Yeah, that was a platform build.

They took Embrace's policies, combined it with a network of wellness plans - things like routine dental cleanings and vaccinations - and now they can cross-sell. The average pet owner spends about four hundred dollars a year on routine vet care plus maybe eight hundred on insurance. If you can capture both, you've got a twelve hundred dollar annual revenue stream per pet. Luna: And the retention is sticky.

People don't switch pet insurers often. They're loyal to their vet, and the policy is tied to the pet's medical history. Lucas: Exactly. Churn rates are below fifteen percent for most carriers.

Compare that to auto insurance, where churn can be thirty percent or higher. The unit economics are really attractive. Luna: But there's a risk, right? The loss ratios can spike if a lot of pets get sick or if a new expensive treatment becomes standard.

I read that cancer treatments for dogs can run ten thousand dollars or more. Lucas: Absolutely. The industry average loss ratio is around seventy-five percent - meaning for every dollar of premium, seventy-five cents goes to claims. That's not super profitable on its own.

The real profit comes from the float: you collect premiums up front, invest the cash, and earn investment income before paying claims. Plus, the data lets you manage the loss ratio better over time. Luna: And the PE firms are also pushing for more standardized policy terms. I've noticed that a lot of the smaller insurers had weird exclusions - like congenital conditions or hereditary issues.

The big players have more consistent coverage. Lucas: Right, and that's part of the consolidation thesis. Standardize the product, centralize the underwriting, and use scale to negotiate better pricing with veterinary networks. Some pe backed platforms are even building their own networks of veterinary clinics - they're not just insuring, they're owning the care delivery.

Luna: So it's a vertical integration play. Insure the pet, own the vet, cross-sell the wellness plan. Lucas: Exactly. And that's where it gets really interesting for the consumer.

On one hand, consolidation could lead to higher premiums if the market becomes less competitive. On the other hand, if the PE firms can reduce administrative costs and improve pricing accuracy, premiums might actually come down. Luna: What's the regulatory landscape like? Insurance is state-regulated, so a national roll-up has to navigate fifty different regulators.

Lucas: It's a patchwork. But most states have relatively light oversight for pet insurance compared to health insurance. There's no ACA for pets. The main regulation is around rate filing and solvency.

A lot of PE firms set up a holding company that owns separate state-level insurers, so the branding is national but the regulatory compliance is local. Luna: That adds complexity but it's not a barrier. We're seeing similar structures in the insurance brokerage roll-ups we covered a few episodes back. Lucas: Good memory.

The playbook is very similar: buy a platform, add tuck-in acquisitions, centralize back-office, and then either sell to a larger financial buyer or take it public. The difference here is the growth rate - pet insurance is growing faster than almost any other property and casualty line. Luna: So where do you see this going over the next three to five years? Lucas: I think we'll see a handful of national players emerge, each backed by a different PE firm.

The market is big enough for maybe four or five major platforms. We'll also likely see more vertical integration - PE firms buying not just insurers, but also veterinary practice management software companies, pet pharmacies, and even genetic testing labs. Luna: The data moat only gets deeper. The more you know about a pet's genetic predispositions, the better you can price the risk.

Lucas: Exactly. And that's the ultimate PE edge: they're not just buying insurance companies, they're buying data assets that get more valuable over time. The pet insurance roll-up is a textbook example of how private equity uses consolidation and data to transform a fragmented industry. Luna: I'll be watching to see if the incumbents like Nationwide and Healthy Paws start acquiring too, or if they get acquired.

Lucas: That's the question. Nationwide is a mutual company, so it's harder to buy. But Healthy Paws is privately held and could be a target at the right price. Either way, the next few years in pet insurance are going to be very active.

Luna: And your dog's premiums may go up - or down - depending on who owns the policy. Lucas: That's the bet. Thanks for listening, and we'll be back next time.